Unlocking the "PAD" lock on rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 63, Issue 4, 2004, Pages 330-332

  Utz, P J ^a,c   Genovese, M C ^a   Robinson, W H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; CITRULLINE; PROTEIN ARGININE DEIMINASE;

ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; CITRULLINATION; HISTORY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ANTIGENS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CITRULLINE; GENE EXPRESSION; HAPLOTYPES; HUMANS; HYDROLASES;

EID: 1842610149     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.015990     Document Type: Short Survey

References (15)

1. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
2. Schellekens G, de Jong B, van den Hoogen F, van de Putte L, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-281.
3. Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
4. Nienhuis R, Mandena E. A new serum factor in patients with rheumatoid arthritis. The perinuclear factor. Ann Rheum Dis 1964;23:302-5.
5. Young B, Mallya R, Leslie R, Clark C, Hamblin T. Antikeratin antibodies in rheumatoid arthritis. BMJ 1979,ii:97-9.
6. van Boekel M, Vossenaar E, van den Hoogen F, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4:87-93.
7. Vossenaar ER, Radstake TRD, van der Heijden A, van Mansum MAM, Dieteren C, de Rooij D-J, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81.
8. Li N, Aoki V, Hans-Filho G, Rivitti E, Diaz L. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (Fago Selvagem). J Exp Med 2003;197:1501-10.
9. Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
10. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003;349:139-45.
11. Hagopian W, Sanjeevi C, Kockum I, Landin-Olsson M, Karlsen A, Sundkvist G, et al. Glutamate decarboxylase, insulin, and islet cell autoantibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95:1505-11.
12. Robinson W, DiGennaro C, Hueber W, Haab B, Kamachi M, Dean E, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8:295-301.
13. Robinson W, Fontoura P, Lee B, deVegvar H, Tom J, Pedotti R, et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotech 2003;21:1033-9.
14. Robinson W, Steinman L, Utz PJ. Protein arrays for autoantibody profiling and fine specificity mapping. Proteomics 2003;3:2077-84.
15. Suzuki A, Yamado R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotype of PADI4, encoding citrullinating enzyme peptidyl arginine deiminase 4, are associated with rheumatoid arthritis. Nat Gene 2003;34:395-402.